FDA Investigating Hospitalizations Linked to Counterfeit Ozempic

Follow Drugslib on

Medically reviewed by Drugs.com.

By Robin Foster HealthDay Reporter

WEDNESDAY, Nov 8, 2023 -- The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides.

At least one of these reports includes mention of a counterfeit version of the Novo Nordisk medication Ozempic, CBS News reported.

Ozempic and Wegovy, another semaglutide medication made by Novo Nordisk, have been tough to find for months as millions of Americans turn to them for weight loss.

In total, 42 reports that mention the use of counterfeit semaglutide were submitted to the FDA's Adverse Event Reporting System through the end of September, CBS News reported. Of those, 28 were classified as "serious," with outcomes that included deaths. All were submitted to the FDA by Novo Nordisk.

However, the records do not prove the counterfeits directly caused the adverse events.

An FDA spokesperson told CBS News that the agency has "no new information to share regarding reports of adverse events" linked to semaglutide counterfeits.

"The FDA will investigate any report of suspect counterfeit drugs to determine the public health risks and the appropriate regulatory response. The FDA remains vigilant in protecting the U.S. drug supply from these threats," agency spokesperson Jeremy Kahn told CBS News.

Meanwhile, Novo Nordisk has said that it is working with the FDA to make consumers aware of the counterfeits and how they differ from the company's products.

"In close collaboration with FDA, we have taken measures to create awareness of the potential for counterfeit products. We have developed a company statement that... includes a guide for identifying counterfeits," a Novo Nordisk spokesperson told CBS News.

The FDA has also voiced concerns over semaglutide alternatives, some of which are manufactured by drug compounders. While compounders are allowed to sell unapproved semaglutide to Americans during the shortage, those aren't scrutinized as carefully as Ozempic and Wegovy are, CBS News reported.

The "FDA has received an increased number of adverse event reports and complaints concerning these compounded drug products," the agency wrote in a letter sent last month to pharmacy boards.

Sources

  • CBS News

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2023-11-08 21:08

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords